Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection

Completed

Conditions studied: COVID-19, Diabetes Mellitus, COVID-19 Pneumonia, COVID-19 Respiratory Infection

In brief

The Coronavirus Disease of 2019 (COVID-19) pandemic has caused an international healthcare crisis and produced a large healthcare burden. Diabetes mellitus is a common disease that can be controlled via pharmacologic agents; however, many patients have poor glycemic control, leading to disease-related complications. Diabetes mellitus has been reported in the literature to be associated with increasing morbidity and mortality in COVID-19 patients, and some hypothesize that this is due to insulin dysregulation propagating a pro-inflammatory state. The investigators aim to contribute to the growing body of literature that assesses the associations between glucose homeostasis and COVID-19 disease severity and mortality.

Key facts

Study ID

NCT05897528

Run by

Arrowhead Regional Medical Center

People needed

589

Starts

2021-10-14

Expected to finish

2022-12-30

Last updated by the study team

2023-06-09

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• COVID-19 confirmed by laboratory testing (ICD10 U07.1)
• Pneumonia due to COVID-19 (ICD10 J12.82)
• Diagnosis of Diabetes Mellitus

You may not qualify if…

• All patients under the age of 18
• COVID in pregnancy

Where it is running

• Arrowhead Regional Medical Center — Colton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.